HD-TAC-7

N/A

Report date: 2023/03/02 16:29:21
NME

Base Information

Drug NameHD-TAC-7
Drug Alias NameHD-TAC7HD-TAC-7
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionHistone deacetylase 3 degraders
TargetsHistone deacetylase 3
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Groningen, The Netherlands
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Groningen, The Netherlands
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A